Kinder Morgan Inc vs Tilray Brands Inc — how do they compare? Kinder Morgan Inc trades at $32.49 (market cap $71.81B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Kinder Morgan Inc is far larger — about 135.4× Tilray Brands Inc's market cap, and Kinder Morgan Inc pays a 3.66% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kinder Morgan Inc for 150 Days and Tilray Brands Inc for 31 Days on average.
| KMI | TLRY | |
|---|---|---|
Market Cap | $71.81B | $530.54M |
Volume | 16,921,908 | 9,099,075 |
Sector | Energy | Health |
52-Week High | $34.31 | $21.00 |
52-Week Low | $25.84 | $3.57 |
Typical Hold Time | 150 Days | 31 Days |
Enterprise Value | $103.86B | $684.46M |
Dividend Yield | 3.66% | — |
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.49, up 2.11% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with revenue growth from $15.1B in 2024 to $16.94B in 2025 and net income margin expanding to 19.31%. Recent earnings beats and a $10B project backlog support growth prospects, while analyst consensus targets $37.20 with 47% buy ratings.
KMI presents a compelling investment case with stable fee-based revenues, dividend yield support, and natural gas infrastructure growth. Key risks include energy market volatility and high debt levels ($29.66B long-term). The stock offers upside potential from current levels but requires monitoring of cash flow sustainability and interest rate sensitivity.
TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.
Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →